Check out this recent Biocompare article by Lauren Tanabe, Ph.D. where Visikol Inc's CSO Tom Villani discusses 3D cell culture models and their use in the [...]
Recently, Visikol began offering drug discovery assay development services to clients that are focused on 3D in vitro cell culture [...]
This past week Visikol participated in Boston Biotech Week and Dr. Michael Johnson pitched during the biotech startup competition and [...]
Our long-term goals as a company are to improve the drug discovery process and the diagnosis of disease. This quarter, [...]
We keep in contact with our sample testers and customers to understand how we can improve our user experience so [...]
Visikol and InSphero App Note Check out Visikol and InSphero's recent application note that features the use of Visikol [...]
This past week Tom Villani (CSO Visikol) gave a featured presentation at the SBI2 conference in San Diego on [...]
Medical imaging has made remarkable leaps and bounds. In today's world, doctors and scientists can generate rich images from a [...]
We always love heading out of the lab to chat with researchers in person to learn about the work that [...]
We are excited to announce that our publication on pairing Visikol TOX with Optical CT imaging was just published in [...]